StudyFinder

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

RECRUITING
I'm interested

18 years to 65 years old
This study is NOT accepting healthy volunteers
Key
Inclusion Criteria:
* Clinical history of T1D with \> 5 years of duration of insulin dependence * At least two episodes of documented severe hypoglycemia in the 12 months prior to enrollment * Stable diabetic treatment * Consistent use of continuous glucose monitor (CGM) for at least 3 months before Screening and willingness to use CGM for the duration of the study Key
Exclusion Criteria:
-Prior islet cell transplant, organ transplant, or cell therapy Other protocol defined Inclusion/Exclusion criteria may apply

BIOLOGICAL: VX-880

Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia

Medical Information - medicalinfo@vrtx.com
Levy, Marlon
PHASE3
HM20021228
NCT04786262
See this study on ClinicalTrials.gov

Back